SLI STANDARD LITHIUM LTD. IFRS
Chemicals & Allied Products · NYSE · SEC CIK 1537137 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q4*2025-12-31 · USD | 2025Q3*2025-09-30 · USD | 2025Q2*2025-06-30 · USD | 2025Q1*2025-03-31 · USD | 2024Q4*2024-12-31 · USD | 2025Q1*2024-09-30 · USD | 2024Q4*2024-06-30 · USD | 2024Q3*2024-03-31 · CAD |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$9.56M | -$6.17M | -$6.55M | -$5.10M | -$5.19M | -$6.17M | -$10.30M | -10.54M |
| Interest expense | $7,000 | $8,000 | $8,000 | $10,000 | $12,000 | $15,000 | $15,000 | 19,000 |
| Pretax income | -$37.77M | -$6.31M | -$5.29M | -$2.12M | -$25.45M | -$5.05M | $154.15M | -$7.67MUSD |
| Income tax | -$2.03M | -$190,000 | -$306,000 | -$567,000 | -$763,000 | -$218,000 | $25.87M | — |
| Net income | -$35.74M | -$6.12M | -$4.98M | -$1.55M | -$117.06M | -$4.83M | $128.28M | -10.36M |
| EPS (basic) | — | -0.03 | -0.03 | -0.01 | — | -0.03 | 0.70 | -0.06 |
| EPS (diluted) | — | -0.03 | -0.03 | -0.01 | — | -0.03 | 0.69 | -0.06 |
| Weighted avg. shares (diluted) | — | 204.02M | 196.60M | 192.57M | — | 184.21M | 185.89M | 178.22M |
| Banking | ||||||||
| Net interest income | $1.13M | $249,000 | $230,000 | $250,000 | $157,000 | $75,000 | $128,000 | 205,000 |
| Balance sheet | ||||||||
| Cash & equivalents | $152.31M | $32.06M | $33.79M | $31.57M | $31.18M | $28.91M | $38.67M | 15.72M |
| Receivables | — | — | — | — | — | $101,000 | $303,000 | 527,000 |
| Current assets | $157.69M | $38.09M | $37.44M | $37.01M | $33.30M | $31.97M | $41.52M | 18.82M |
| PP&E, netmay include right-of-use assets (IFRS) | $1.04M | $1.10M | $1.19M | $1.41M | $1.63M | $1.34M | $1.51M | 3.18M |
| Intangibles | $967,000 | $969,000 | $1.00M | $949,000 | $943,000 | $980,000 | $985,000 | 1.37M |
| Total assets | $386.52M | $286.86M | $275.40M | $265.66M | $259.50M | $278.60M | $287.29M | 171.09M |
| Current liabilities | $10.09M | $9.14M | $6.84M | $5.68M | $5.77M | $7.32M | $12.60M | 11.15M |
| Short-term debt | $0 | — | — | — | $0 | $0 | — | — |
| Total liabilities | $32.56M | $33.74M | $31.55M | $30.72M | $31.44M | $33.34M | $38.91M | 11.80M |
| Shareholders' equity | $353.96M | $253.12M | $243.85M | $234.94M | $228.06M | $245.26M | $248.38M | 159.29M |
| Cash flow statement | ||||||||
| Operating cash flow | — | — | — | — | — | — | — | — |
| Capital expenditure | — | — | — | — | $0 | $10,000 | — | 0 |
| Investing cash flow | -$9.54M | -$11.99M | -$8.27M | $35,000 | -$320,000 | -$2.08M | $28.73M | -$5.13MUSD |
| Financing cash flow | $132.55M | $13.16M | $10.97M | $6.89M | $6.75M | -$149,000 | $1.81M | $10.55MUSD |
| Stock-based compensation | $1.50M | $1.80M | $1.87M | $1.42M | $1.20M | $894,000 | $570,000 | $2.68MUSD |
Free plan shows the latest 8 periods; Pro shows all 22 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.